Nissui Pharmaceutical financials at a glance

Year Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥14.07B ¥14.44B ¥14.34B ¥14.50B ¥14.39B ¥12.46B ¥13.28B ¥0.00M ¥0.00M ¥0.00M ¥0.00M ¥0.00M ¥12.83B ¥12.33B ¥12.55B ¥12.77B ¥12.38B ¥16.66B ¥0.00M ¥0.00M
GM % Gross Margin %
55.34% 54.41% 52.88% 50.38% 48.61% 48.97% 51.01% 0.00% 0.00% 0.00% 0.00% 0.00% 49.77% 47.47% 45.88% 44.83% 33.90% 31.57% 0.00% 0.00%
OM Operating Margin
7.39% 8.82% 7.94% 8.17% 8.75% 11.13% 13.79% 0.00% 0.00% 0.00% 0.00% 0.00% 13.24% 11.58% 10.46% 8.97% 6.41% 9.39% 0.00% 0.00%
EPS Earnings Per Share
¥0.00 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
22.55m 22.55m 44.82m 22.4m 22.4m 22.4m 22.4m 22.4m 22.4m 22.4m 22.4m 22.4m 22.4m 22.4m 22.39m 22.39m 22.39m 22.39m 9.84m 0m
OCF Operating Cash Flow
¥857.00M ¥1.45B ¥676.34M ¥1.16B ¥1.04B ¥2.16B ¥1.63B ¥0.00M ¥0.00M ¥0.00M ¥0.00M ¥0.00M ¥1.10B ¥865.00M ¥1.36B ¥1.49B ¥485.00M ¥1.01B ¥0.00M ¥0.00M
FCF Free Cash Flow
¥434.00M ¥1.20B ¥425.87M ¥260.92M ¥353.23M ¥2.04B ¥1.47B ¥1.77B ¥1.47B ¥1.45B ¥1.01B ¥695.00M ¥638.00M ¥355.00M ¥1.04B ¥-50.00M ¥364.00M ¥957.00M ¥0.00M ¥0.00M
FCFS Free Cash Flow Per Share
¥17.99 ¥52.21 ¥18.72 ¥11.48 ¥14.29 ¥89.64 ¥63.80 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥27.91 ¥15.23 ¥44.52 ¥-3.44 ¥15.14 ¥40.55 ¥0.00 ¥0.00